Manulife (International) Limited ("MIL") maintains a strong regulatory capital position. As at December 31, 2025, MIL's capital base increased to HK$89.0 billion, and its capital base-to-prescribed capital amount ratio stood at 234%. Looking ahead, MIL will continue to maintain resilient capital buffers to keep its capital base above the prescribed capital amount, ensuring that MIL can withstand market volatility and fluctuations in operational experience.
Manulife (International) Limited (“MIL”) maintains a strong regulatory capital position, with a capital base of HK$67.4 billion as of December 31, 2024 and a capital base-to-prescribed capital amount ratio of 256%. Looking ahead, MIL will continue to maintain resilient capital buffers, so that the capital base remains above the prescribed capital amount to ensure that MIL can withstand market volatility and fluctuations in operational experience.